"Patient enrolment in BNC210 exploratory clinical trial to treat Agitation in elderly patients in a hospital/nursing home setting is now complete and top line data are expected by the end of June 2019."
That's all I needed to hear.
- Forums
- ASX - By Stock
- BNO
- Ann: Strategic Review Outcome and Program Updates
Ann: Strategic Review Outcome and Program Updates, page-4
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)